@article{db04d1b612454db4941cd79c138c9298,
title = "Pharmacokinetics of darunavir/ritonavir with etravirine both twice daily in human immunodeficiency virus-infected adolescents and young adults",
abstract = "Data on the combination of darunavir/ritonavir and etravirine both given twice daily in adolescents/young adults are lacking. In this study, we assessed the pharmacokinetics of darunavir/ ritonavir 600/100 mg with etravirine 200 mg twice daily in 36 treatment-experienced human immunodeficiency virus-infected adolescents and young adults and found that exposures were comparable to those reported in adults.",
keywords = "Antiretrovirals, Darunavir, Etravirine, Pediatrics, Ritonavir",
author = "{for the IMPAACT P1058A Team} and Cressey, {Tim R.} and Ram Yogev and Andrew Wiznia and Rohan Hazra and Patrick Jean-Philippe and Bobbie Graham and Amy Gonzalez and Paula Britto and Carey, {Vincent J.} and Fletcher, {Courtney V.} and Acosta, {Edward P.}",
note = "Funding Information: Financial support. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases of the NIH under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), and UM1AI106716 (IMPAACT LC), with cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health. Publisher Copyright: {\textcopyright} The Author 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved.",
year = "2017",
month = sep,
day = "1",
doi = "10.1093/jpids/piw017",
language = "English (US)",
volume = "6",
pages = "294--296",
journal = "Journal of the Pediatric Infectious Diseases Society",
issn = "2048-7193",
publisher = "Oxford University Press",
number = "3",
}